Program Intensive Habilitation (PIH) for Young Children With Early Brain Damage
PIHMulti
Evaluation of a Norwegian Model of an Intensive Habilitation Program for Young Children With Early Brain Damage - a Multicentre Randomized Controlled Trial.
1 other identifier
interventional
90
1 country
1
Brief Summary
By longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in order to treat and reduce the consequences of early brain damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2021
CompletedStudy Start
First participant enrolled
October 10, 2021
CompletedFirst Posted
Study publicly available on registry
October 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 21, 2025
May 1, 2025
4.1 years
September 28, 2021
May 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT)
Primary evaluation measure for the child
Change from baseline measure at 12 months and after 24 months
Change in Family Empowerment Scale (FES)
Primary evaluation measure for the parents
Change from baseline measure at12 months and after 24 months
Secondary Outcomes (2)
Change in Gross motor function measure (GMFM-88)
Change from baseline measure at 12 months and after 24 months
Change in Parenting Stress Index (PSI)
Change from baseline measure at 12 months and after 24 months
Study Arms (2)
Intervention group
EXPERIMENTALHalf of the study participants will be randomized to the intensive habilitation program the first year of program. The second year of program this group of participants will be offered habilitation "as usual".
Control group
OTHERHalf of the study participants will be randomized to "treatment as usual" the first year of program, then offered the intensive program during the second year ("stepped wedge design").
Interventions
The program is based on a holistic and family-centered concept, which acknowledges parents as experts on their child's abilities and needs. The program involves both parents and local professionals, and includes goal setting and goal-directed treatment targeted to the needs of the individual child. The program lasts for about one year and contains three in-patient group sessions over 2 weeks. In between the children are receiving individualized home training programs at home and in pre-school/kindergarten. The children train on a daily basis, both during the inpatient sessions and in the home setting.
When the participants are not joining the study year containing the intervention program, they will be offered habilitation services "as usual" administered by the primary health care services in the local community.
Eligibility Criteria
You may qualify if:
- age 2 - 6 years at the start of the program
- a diagnosis of severe cerebral palsy or similar motor disability of non-progressive etiology (GMFCS level IV-V),
- being able to participate in group sessions
- having parents who want to take an active part in their child's training
- least one of the parents must speak fluent Norwegian or English.
You may not qualify if:
- children with progressive disorders
- co-morbidity like autism spectrum disorder, severe visual and hearing impairments or intractable epilepsy that worsen with physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sorlandet Hospital HFlead
- Haukeland University Hospitalcollaborator
- St. Olavs Hospitalcollaborator
- University Hospital of North Norwaycollaborator
Study Sites (1)
Sørlandet Hospital
Kristiansand, 4626, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jon Skranes
Sørlandet Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinded evaluation by independent researchers at baseline, at 12 months and at 24 months.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor dr med
Study Record Dates
First Submitted
September 28, 2021
First Posted
October 26, 2021
Study Start
October 10, 2021
Primary Completion
October 31, 2025
Study Completion
December 31, 2025
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share